Drug Shortage Report for DEXTROSE INJECTION

Last updated on 2024-03-22

Report ID 201190
Drug Identification Number 02517132
Brand name DEXTROSE INJECTION
Common or Proper name Dextrose Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-08-07
Estimated end date 2024-05-01
Actual end date 2024-03-21
Shortage status Resolved
Updated date 2024-03-22
Company comments
Health Canada comments
Tier 3 Status Yes
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2024-03-22 English Compare
v25 2024-03-21 French Compare
v24 2024-03-21 English Compare
v23 2024-03-21 English Compare
v22 2024-01-30 French Compare
v21 2024-01-30 English Compare
v20 2023-12-19 French Compare
v19 2023-12-19 English Compare
v18 2023-11-27 French Compare
v17 2023-11-27 English Compare
v16 2023-11-06 French Compare
v15 2023-11-06 English Compare
v14 2023-10-30 French Compare
v13 2023-10-30 English Compare
v12 2023-10-16 French Compare
v11 2023-10-16 French Compare
v10 2023-10-16 English Compare
v9 2023-09-11 French Compare
v8 2023-09-11 English Compare
v7 2023-09-05 English Compare

Showing 1 to 20 of 26